Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use

[11] Oberste MS(2014)The potential impact of expanding target age groups for polio immunization campaigns BMC Infect Dis 14 45-1812

[12] Diop O(2013)Expert review on poliovirus immunity and transmission Risk Anal 33 544-S423

[13] Wassilak SGF(2013)Review and assessment of poliovirus immunity and transmission: Synthesis of knowledge gaps and identification of research needs Risk Anal 33 606-8704

[14] Cochi SL(2015)Modeling options to manage type 1 wild poliovirus imported into Israel in 2013 J Infect Dis 211 1800-6

[15] Thompson KM(2014)Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria J Infect Dis 210 S412-S411

[16] Kew OM(2009)Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine J Virol 83 8693-undefined

[17] Sutter RW(1991)Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines J Infect Dis 163 1-undefined

[18] de Gourville EM(2015)Combinations of quality and frequency of immunization activities to stop and prevent poliovirus transmission in the high-risk area of northwest Nigeria PLoS One 10 e0130123-undefined

[19] Dowdle WR(2014)Modeling strategies to increase population immunity and prevent poliovirus transmission in two high-risk areas in northern India J Infect Dis 210 S398-undefined

[20] Pallansch MA(2015)Modeling undetected live poliovirus circulation after apparent interruption of transmission: Implications for surveillance and vaccination BMC Infect Dis 15 1-undefined

[11] Oberste MS(2014)The potential impact of expanding target age groups for polio immunization campaigns BMC Infect Dis 14 45-1812

[12] Diop O(2013)Expert review on poliovirus immunity and transmission Risk Anal 33 544-S423

[13] Wassilak SGF(2013)Review and assessment of poliovirus immunity and transmission: Synthesis of knowledge gaps and identification of research needs Risk Anal 33 606-8704

[14] Cochi SL(2015)Modeling options to manage type 1 wild poliovirus imported into Israel in 2013 J Infect Dis 211 1800-6

[15] Thompson KM(2014)Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria J Infect Dis 210 S412-S411

[16] Kew OM(2009)Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine J Virol 83 8693-undefined

[17] Sutter RW(1991)Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines J Infect Dis 163 1-undefined

[18] de Gourville EM(2015)Combinations of quality and frequency of immunization activities to stop and prevent poliovirus transmission in the high-risk area of northwest Nigeria PLoS One 10 e0130123-undefined

[19] Dowdle WR(2014)Modeling strategies to increase population immunity and prevent poliovirus transmission in two high-risk areas in northern India J Infect Dis 210 S398-undefined

[20] Pallansch MA(2015)Modeling undetected live poliovirus circulation after apparent interruption of transmission: Implications for surveillance and vaccination BMC Infect Dis 15 1-undefined